Form 4: Bluebird Bio CEO Andrew Obenshain Sells Shares to Cover Tax Obligations

Andrew Obenshain, President and CEO of bluebird bio, Inc., sold 921 shares of common stock on March 3, 2025, to cover tax withholding obligations.

Summary

• On March 3, 2025, Andrew Obenshain, the President and CEO of bluebird bio, Inc., sold 921 shares of common stock.
• The sale was executed at an average weighted price of $3.9194, with prices ranging from $3.85 to $4.09.
• The transaction was conducted to cover tax withholding obligations related to the vesting of Restricted Stock Units.
• Following the transaction, Obenshain directly owns 18,327 shares of bluebird bio, Inc.
• The sale was reported on a Form 4 filing with the Securities and Exchange Commission (SEC).

Sentiment

Score: 5

Explanation: The document reports a routine transaction (stock sale for tax obligations) and does not contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is a routine part of executive compensation and tax management.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on shareholder perception, but is unlikely to be significant given the reason for the sale.

Key Dates